Trials / Completed
CompletedNCT06278766
A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose Administration
Mass Balance Study of [14C] ABBV-552 in Healthy Male Volunteers Following Single Oral Dose Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate mass balance, pharmacokinetics and safety of \[14C\] ABBV-552 in healthy, male volunteers following administration of a single oral dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-552 | Oral Solution |
Timeline
- Start date
- 2024-02-21
- Primary completion
- 2024-04-19
- Completion
- 2024-04-19
- First posted
- 2024-02-26
- Last updated
- 2024-04-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06278766. Inclusion in this directory is not an endorsement.